Investigating the role of innate immunity in mediating the non-specific effects of Bacille Calmette Guerin (BCG) vaccine -Dr Bridget Freyne
Epidemiological evidence suggests that Bacillus Calmette-Guerin (BCG) vaccine exerts non-specific (heterologous) effects in infants; decreasing neonatal mortality in high-mortality settings and preventing allergy and morbidity from infection in developed countries. New tuberculosis (TB) vaccines could potentially lack these beneficial effects. Immune mechanisms underlying the non-specific effects of BCG vaccine have been linked to ‘trained immunity’ or innate immune memory.
Follow Dr Freyne's Work
